CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
192 hedge funds and large institutions have $3.27B invested in Clovis Oncology, Inc. in 2015 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 88 increasing their positions, 45 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 13 → 13 (0)
4% less call options, than puts
Call options by funds: $49.6M | Put options by funds: $51.5M
Holders
192
Holding in Top 10
13
Calls
$49.6M
Puts
$51.5M
Top Buyers
| 1 | +$120M | |
| 2 | +$76.9M | |
| 3 | +$65.1M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$55.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$38.4M |
Top Sellers
| 1 | -$53.4M | |
| 2 | -$26.6M | |
| 3 | -$23.7M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$21.7M |
| 5 |
PC
PointState Capital
New York
|
-$18.9M |